Position in ANIP
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,156,183
+$3,023,047 QoQ
Shares Held
74,368
+82.5% QoQ
Ownership
0.324%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#66
of 305 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ANIP Over Time
Shares Held
Position Value (USD)
Derivatives in ANIP
reported options exposure · as of Mar 31, 2026CallValue
$3,168,280
CallShares
41,200
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026BOOTHBAY FUND MANAGEMENT, LLC holds $84,777,886 across 22 Drug Manufacturers - Specialty & Generic names. ANIP ranks #3 (7.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LQDA |
Liquidia Corp
|
622,716 | $49,649,146 | |
| 2 | ANIK |
Anika Therapeutics, Inc.
|
529,640 | $7,748,633 | |
| 3 | ANIP |
Ani Pharmaceuticals Inc
This page
|
74,368 | $6,156,183 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
90,928 | $3,080,640 | |
| 5 | VTRS |
Viatris Inc
|
188,731 | $2,997,048 | |
| 6 | ETON |
Eton Pharmaceuticals, Inc.
|
57,516 | $2,082,079 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
11,814 | $1,991,131 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
56,774 | $1,968,354 |
All Filings in ANIP
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,156,183 | 74,368 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $3,133,136 | 40,743 | Shares | Other | 2026-05-15 | |
| 2026-03-31 | $3,168,280 | 41,200 | Call | Other | 2026-05-15 | |
| 2025-12-31 | $1,784,044 | 22,600 | Call | Other | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||